Fisher Asset Management
NBIX icon

Fisher Asset Management’s Neurocrine Biosciences NBIX Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$11M Sell
87,540
-7,717
-8% -$970K ﹤0.01% 400
2025
Q1
$10.5M Buy
95,257
+3,153
+3% +$349K ﹤0.01% 409
2024
Q4
$12.6M Buy
92,104
+23,834
+35% +$3.25M 0.01% 407
2024
Q3
$7.87M Buy
68,270
+4,930
+8% +$568K ﹤0.01% 445
2024
Q2
$8.72M Sell
63,340
-1,826
-3% -$251K ﹤0.01% 431
2024
Q1
$8.99M Buy
65,166
+4,939
+8% +$681K ﹤0.01% 437
2023
Q4
$7.94M Sell
60,227
-1,600
-3% -$211K ﹤0.01% 441
2023
Q3
$6.96M Sell
61,827
-179
-0.3% -$20.1K ﹤0.01% 480
2023
Q2
$5.85M Sell
62,006
-2,136
-3% -$201K ﹤0.01% 523
2023
Q1
$6.49M Sell
64,142
-126
-0.2% -$12.8K ﹤0.01% 508
2022
Q4
$7.68M Sell
64,268
-848
-1% -$101K 0.01% 485
2022
Q3
$6.92M Sell
65,116
-5,362
-8% -$570K 0.01% 436
2022
Q2
$6.87M Sell
70,478
-4,178
-6% -$407K ﹤0.01% 388
2022
Q1
$7M Buy
74,656
+9
+0% +$844 ﹤0.01% 409
2021
Q4
$6.36M Buy
74,647
+5,453
+8% +$464K ﹤0.01% 432
2021
Q3
$6.64M Buy
69,194
+7,545
+12% +$724K ﹤0.01% 396
2021
Q2
$6M Buy
61,649
+3,473
+6% +$338K ﹤0.01% 409
2021
Q1
$5.66M Buy
58,176
+746
+1% +$72.6K ﹤0.01% 416
2020
Q4
$5.51M Sell
57,430
-1,791
-3% -$172K ﹤0.01% 409
2020
Q3
$5.7M Sell
59,221
-4,006
-6% -$385K 0.01% 384
2020
Q2
$7.71M Sell
63,227
-1,340
-2% -$163K 0.01% 351
2020
Q1
$5.59M Sell
64,567
-2,208
-3% -$191K 0.01% 345
2019
Q4
$7.18M Sell
66,775
-6,252
-9% -$672K 0.01% 368
2019
Q3
$6.58M Sell
73,027
-1,393
-2% -$126K 0.01% 408
2019
Q2
$6.28M Buy
74,420
+47,257
+174% +$3.99M 0.01% 408
2019
Q1
$2.39M Sell
27,163
-477
-2% -$42K ﹤0.01% 500
2018
Q4
$1.97M Sell
27,640
-507
-2% -$36.2K ﹤0.01% 522
2018
Q3
$3.46M Sell
28,147
-3,195
-10% -$393K ﹤0.01% 463
2018
Q2
$3.08M Buy
+31,342
New +$3.08M ﹤0.01% 491
2018
Q1
Sell
-5,025
Closed -$390K 807
2017
Q4
$390K Sell
5,025
-28
-0.6% -$2.17K ﹤0.01% 684
2017
Q3
$310K Buy
+5,053
New +$310K ﹤0.01% 678